CoChat

GRcalculator: an online tool for calculating and mining dose–response data

Open access

The DOI matches its Crossref record; the references it cites are not checked yet.

Abstract

BACKGROUND: , are confounded by the number of cell divisions taking place during the assay, which varies widely for biological and experimental reasons. Hafner et al. (Nat Meth 13:521-627, 2016) recently proposed an alternative way to quantify drug response, normalized growth rate (GR) inhibition, that is robust to such confounders. Adoption of the GR method is expected to improve the reproducibility of dose-response assays and the reliability of pharmacogenomic associations (Hafner et al. 500-502, 2017). RESULTS: We describe here an interactive website ( www.grcalculator.org ) for calculation, analysis, and visualization of dose-response data using the GR approach and for comparison of GR and traditional metrics. Data can be user-supplied or derived from published datasets. The web tools are implemented in the form of three integrated Shiny applications (grcalculator, grbrowser, and grtutorial) deployed through a Shiny server. Intuitive graphical user interfaces (GUIs) allow for interactive analysis and visualization of data. The Shiny applications make use of two R packages (shinyLi and GRmetrics) specifically developed for this purpose. The GRmetrics R package is also available via Bioconductor and can be used for offline data analysis and visualization. Source code for the Shiny applications and associated packages (shinyLi and GRmetrics) can be accessed at www.github.com/uc-bd2k/grcalculator and www.github.com/datarail/gr_metrics . CONCLUSIONS: GRcalculator is a powerful, user-friendly, and free tool to facilitate analysis of dose-response data. It generates publication-ready figures and provides a unified platform for investigators to analyze dose-response data across diverse cell types and perturbagens (including drugs, biological ligands, RNAi, etc.). GRcalculator also provides access to data collected by the NIH LINCS Program ( http://www.lincsproject.org /) and other public domain datasets. The GRmetrics Bioconductor package provides computationally trained users with a platform for offline analysis of dose-response data and facilitates inclusion of GR metrics calculations within existing R analysis pipelines. These tools are therefore well suited to users in academia as well as industry.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12885-017-3689-3

Cites

Statistics

Figures

Fig. 1 GRcalculator Shiny applications (grtutorial, grcalculator, and grbrowser) (http://www.grcalculator.org). A schematic of the GRcalculator homepage showing links to each of the Shiny applications that comprise it
Fig. 1 GRcalculator Shiny applications (grtutorial, grcalculator, and grbrowser) (http://www.grcalculator.org). A schematic of the GRcalculator homepage showing links to each of the Shiny applications that comprise itCC BY · PubMed Central
Fig. 2 Dose–response model interactive Exploration Tool. Interactive graphs with parameters controlled by sliders show the behavior of the traditional dose–response curve (center) versus that of the normalized growth rate inhibition (GR) curve (right). Derived traditional dose–response model parameters IC 50 and E inf are displayed along with the analogous GR model parameters GR 50 and GR inf. Cell population growth at different concentrations of a drug is shown over a typical 3-day assay (left). Traditional dose–response curve values and GR curve values at these concentrations are marked by similarly colored points on the center and right plots. Buttons (bottom) set parameter values to those of a typical cytostatic, partial cytostatic, or cytotoxic drug
Fig. 2 Dose–response model interactive Exploration Tool. Interactive graphs with parameters controlled by sliders show the behavior of the traditional dose–response curve (center) versus that of the normalized growth rate inhibition (GR) curve (right). Derived traditional dose–response model parameters IC 50 and E inf are displayed along with the analogous GR model parameters GR 50 and GR inf. Cell population growth at different concentrations of a drug is shown over a typical 3-day assay (left). Traditional dose–response curve values and GR curve values at these concentrations are marked by similarly colored points on the center and right plots. Buttons (bottom) set parameter values to those of a typical cytostatic, partial cytostatic, or cytotoxic drugCC BY · PubMed Central
Fig. 3 Calculating GR values and fitting dose–response curves for user-supplied data. A flowchart showing a typical GRcalculator workflow
Fig. 3 Calculating GR values and fitting dose–response curves for user-supplied data. A flowchart showing a typical GRcalculator workflowCC BY · PubMed Central
Fig. 4 Mining LINCS and published datasets. A flowchart showing a typical GRbrowser workflow
Fig. 4 Mining LINCS and published datasets. A flowchart showing a typical GRbrowser workflowCC BY · PubMed Central
Fig. 5 GRmetrics R package. Sample code and output showing generation of an interactive visualization of GR dose–response curves using the GRmetrics R package
Fig. 5 GRmetrics R package. Sample code and output showing generation of an interactive visualization of GR dose–response curves using the GRmetrics R packageCC BY · PubMed Central
Fig. 6 grbrowser use-case with gCSI data. An example use-case of the grbrowser with the gCSI dataset, reproducing a result from Hafner et al. [3]. Steps show how to use the grbrowser to filter the dataset to breast cancer cell lines treated with lapatinib and compare the sensitivity of wild-type PTEN cell lines with that of mutant PTEN cell lines using GR 50 and IC 50. In this case, use of the GR 50 produces a known result (p-value 0.0033), that PTEN loss-of-function mutations mediate resistance to lapatinib in breast cancer cells, which IC 50 fails to produce at a statistically significant level (p-value 0.12) because of large differences in growth rates between the wild-type and mutant cell lines. p-values were calculated using a two-sided Wilcoxon rank-sum test. IC 50 and GR 50 values were capped at 31 μM
Fig. 6 grbrowser use-case with gCSI data. An example use-case of the grbrowser with the gCSI dataset, reproducing a result from Hafner et al. [3]. Steps show how to use the grbrowser to filter the dataset to breast cancer cell lines treated with lapatinib and compare the sensitivity of wild-type PTEN cell lines with that of mutant PTEN cell lines using GR 50 and IC 50. In this case, use of the GR 50 produces a known result (p-value 0.0033), that PTEN loss-of-function mutations mediate resistance to lapatinib in breast cancer cells, which IC 50 fails to produce at a statistically significant level (p-value 0.12) because of large differences in growth rates between the wild-type and mutant cell lines. p-values were calculated using a two-sided Wilcoxon rank-sum test. IC 50 and GR 50 values were capped at 31 μMCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

The citation lists are queued

They are fetched later and appear here then.

References 15 · Cited by 121

Research works printed but not linked: 2

  1. Niepel M, Hafner M, Duan Q, Wang Z, Paull EO, Chung M, Lu X, Stuart JM, Golub TR, Subramanian A, Ma'ayan A, Sorger PK. Transcriptional landscape of drug response guides the design of specific and potent drug combinations. Nat Commun. In Press.
  2. Hafner M, Niepel M, Sorger PK. Alternative drug sensitivity metrics improve preclinical cancer pharmacogenomics. Nat Biotech. 2017;35:500–2. · DOI · Paper page

Metadata

Authors
Clark, N. A., Hafner, M., Kouril, M., Williams, E. H., Muhlich, J. L., Pilarczyk, M., Niepel, M., Sorger, P. K., & Medvedovic, M.
Affiliations
  • University of Cincinnati (US)
  • Harvard University (US)
  • Cincinnati Children's Hospital Medical Center (US)
Corresponding author
Medvedovic, Mario
Venue
BMC Cancer
Published
2017-10-24
Volume
17
Issue
1
Pages
698-698
ISSN
1471-2407 (ISSN-L)
OpenAlex
W2554439427
Cited by
121
References
15
Citations by year
2026: 9 · 2025: 12 · 2024: 23 · 2023: 28 · 2022: 16 · 2021: 8 · 2020: 12 · 2019: 6 · 2018: 4 · 2017: 3
FWCI
5.12
Type
journal article
Language
en
Open access
Licence
Locations
  • BMC Cancer (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
National Institutes of Health (U54-HL127624, U54-HL127365)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biophysics › Cell Image Analysis Techniques
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
Keywords
dose-response analysis, Shiny app, pharmacogenomics, data visualization, R/Bioconductor package
MeSH terms
Animals, Cell Line, Dose-Response Relationship, Drug, Humans, Software, Reproducibility of Results, Data Mining

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: GRcalculator: an online tool for calculating and mining dose–response data. https://app.cochat.ai/papers/10.1186/s12885-017-3689-3
The paper
Clark, N. A., Hafner, M., Kouril, M., Williams, E. H., Muhlich, J. L., Pilarczyk, M., Niepel, M., Sorger, P. K., & Medvedovic, M. (2017). GRcalculator: an online tool for calculating and mining dose–response data. BMC Cancer. https://doi.org/10.1186/s12885-017-3689-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.